₹ 10.38
0.01 (0.10%)
N
Nectar Lifesciences
₹ 10.38
Nectar Lifesciences EPS Summary (consolidated)
The latest quarterly EPS of Nectar Lifesciences as of Q1 Jun 2026 stands at ₹-0.79. This is a 76.63% growth quarter on quarter and 71.99% growth same quarter last year. For the FY2026 the EPS of Nectar Lifesciences stands at ₹-13.40. This is a 164.30% fall compared with FY2025.
Nectar Lifesciences EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

